Incidence and treatment of pelvic organ prolapse after radical cystectomy: a systematic review

Schultink M1, Coolen A2, Tijsseling D2, Withagen M3

Research Type

Clinical

Abstract Category

Pelvic Organ Prolapse

Gold Pass video coming soon
Find out more

Abstract 317
POP, Incontinence and Imaging 2
Scientific Podium Short Oral Session 33
Friday 9th October 2026
16:30 - 16:37
Parallel Hall 3
0.4 Brussels / 0.5 Paris
Capacity: 356
Female Pelvic Organ Prolapse Prolapse Symptoms Surgery
1. Utrecht University, 2. Bergman Clinics, 3. UMC Utrecht
Presenter
Links

Abstract

Hypothesis / aims of study
Pelvic organ prolapse (POP) is a recognized complication following radical cystectomy (RC). However, there remains ongoing debate regarding its incidence and the optimal (surgical) management of post-RC POP. The aim of this systematic review was to provide a comprehensive overview of the available literature on the incidence and treatment options for POP in patients who have undergone radical cystectomy.
Study design, materials and methods
This systematic review was conducted in accordance with PRISMA guidelines [1]. Studies were included if they assessed the incidence or treatment options for POP in patients with radical pelvic surgery in which at least the bladder and other pelvic organs were removed, e.g. radical cystectomy and anterior exenteration. Studies exclusively reporting vaginal evisceration were excluded. Given the paucity of high-level evidence, all study designs were eligible, including case reports and case series. A systematic search of PubMed and Embase was conducted up to 22 October 2025 using the following search terms: ("Pelvic organ prolapse"[Mesh] OR prolaps*[tiab] OR POP[tiab] OR enterocele[tiab] OR rectocele[tiab] OR ("perineal"[tiab] AND "hernia*"[tiab]) OR "pelvic descent"[tiab] OR "vaginal dehiscence"[tiab]) AND ("cystectomy"[Mesh] OR "cystectom*"[tiab] OR Bricker[tiab] OR "Wallace"[tiab] OR studer[tiab] OR "cutaneous ureterostomy"[tiab] OR Nesbit[tiab] OR "ileal conduit"[tiab] OR "neobladder"[tiab] OR "pelvic exenteration"[mesh] OR "anterior exenteration"[tiab] OR "pelvic exenteration"[tiab] OR "pelvic resection"[tiab])
Results
Titles and abstracts were assessed for eligibility in a standardized manner by 3 independent reviewers. Disagreements were resolved by the assessment of the abstract by a fourth reviewer. The search yielded 439 citations. A total of 84 full text articles were screened. A total of 31 studies met the inclusion criteria. Seven studies reported on the incidence of post-RC POP, with reported rates ranging from 0.5% to 6%. However, higher rates of POP-related findings were observed in studies assessing POP using radiological imaging (96%) or patient-reported questionnaires (11%).
Interpretation of results
23 studies (all case reports or case series) described surgical management techniques for post-RC POP, encompassing a total of 48 patients. The majority of patients (n = 39, 81%) were treated via a transvaginal approach, while 5 patients (10%) underwent laparoscopic procedures and 4 patients (8%) were treated via an open abdominal approach. Mesh was utilized in 16 patients (33%). The various surgical approaches are illustrated in Figure 1, demonstrating both vaginal and abdominal placement options. The median follow-up duration was 12 months (range 3–60 months). An overview of the surgical techniques is provided in Figure 1 and Table 1.
Concluding message
There is a clear lack of high-quality evidence regarding both the incidence and management of post-RC POP. Retrospective studies suggest an incidence ranging from 0.5% to 6%. A wide variety of surgical techniques has been described, with the transvaginal approach being most commonly employed; however, abdominal approaches (open or laparoscopic) also appear to be feasible. Due to the absence of high-quality comparative studies, no definitive conclusions can be drawn regarding the relative effectiveness of the different surgical techniques. Further research is warranted to determine the optimal management strategy for post-RC POP.
Figure 1 Figure 1. Route of treatment options for post-RC POP
Figure 2 Table 1. Treatment options for post-RC POP
References
  1. M.J.Page, The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, BMJ 2021; 372
Disclosures
Funding - Clinical Trial No Subjects Human Ethics not Req'd it is a systematic review Helsinki Yes Informed Consent No AI For simple textual assistance in writing the abstract manuscript
Citation

Continence 19S (2026) 102794
DOI: 10.1016/j.cont.2026.102794

26/10/2026 04:41:31